Yu, Jiang External Author

Publications

Sort by

Selected publications

  • Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myelomaBlood2014 Academic Article GET IT
    Times cited: 88